ACUTE ELECTROPHYSIOLOGIC EFFECTS OF AMIODARONE IN PATIENTS WITH CONGESTIVE-HEART-FAILURE

被引:14
作者
RIGGIO, DW
PETERS, RW
FELICIANO, Z
GOTTLIEB, SS
SHOROFSKY, SR
GOLD, MR
机构
[1] DEPT VET AFFAIRS MED CTR,DIV CARDIOL,BALTIMORE,MD 21201
[2] UNIV MARYLAND,SCH MED,DEPT MED,DIV CARDIOL,BALTIMORE,MD 21201
关键词
D O I
10.1016/S0002-9149(99)80749-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with severe congestive heart failure (CHF) are at increased risk for atrial and ventricular arrhythmias and sudden cardiac death. Amiodarone is generally well tolerated by this population and has a low proarrhythmic potential. Because of its peculiar kinetics, amiodarone requires a prolonged loading period, necessitating lengthy hospitalizations in a monitored setting. This study was planned prospectively to assess the electrophysiologic effects of an abbreviated high-dose oral load of amiodarone in patients with severe CHF and known or suspected life-threatening ventricular arrhythmias. Fifteen patients with stable CHF and known or suspected life-threatening ventricular arrhythmias underwent baseline electrophysiologic study. The study was repeated after administration of oral amiodarone, 50 mg/kg/day for 2 days in 8 divided doses (mean dose 6.9 +/- 0.4 g). After amiodarone administration, there was prolongation in virtually all conduction times and refractory periods. The prolongation of refractoriness was most pronounced in the atrium, Ventricular effective refractory periods demonstrated reverse frequency dependence. We conclude that a brief high-dose oral load of amiodarone is well tolerated by patients with CHF. It has marked and diffuse electrophysiologic actions suggestive of class I and III effects in addition to antiadrenergic and calcium blocking action. These effects are especially pronounced in the atrium.
引用
收藏
页码:1158 / 1161
页数:4
相关论文
共 19 条
[1]  
Bazett HC, 1920, HEART-J STUD CIRC, V7, P353
[2]  
CLELAND JGF, 1987, BRIT HEART J, V57, P436
[3]  
EVANS SJL, 1992, J AM COLL CARDIOL, V19, P169
[4]   LONG-TERM RECORDING OF MONOPHASIC ACTION-POTENTIALS FROM HUMAN ENDOCARDIUM [J].
FRANZ, MR .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (10) :1629-1634
[5]   LOW-DOSE AMIODARONE FOR MAINTENANCE OF SINUS RHYTHM AFTER CARDIOVERSION OF ATRIAL-FIBRILLATION OR FLUTTER [J].
GOSSELINK, ATM ;
CRIJNS, HJGM ;
VANGELDER, IC ;
HILLIGE, H ;
WIESFELD, ACP ;
LIE, KI .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (24) :3289-3293
[6]   HIGH-DOSE ORAL AMIODARONE LOADING EXERTS IMPORTANT HEMODYNAMIC ACTIONS IN PATIENTS WITH CONGESTIVE-HEART-FAILURE [J].
GOTTLIEB, SS ;
RIGGIO, DW ;
LAURIA, S ;
PETERS, RW ;
SHOROFSKY, SR ;
CINES, M ;
FROMAN, D ;
GOLD, MR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (03) :560-564
[7]   BENEFICIAL-EFFECTS OF LOW-DOSE AMIODARONE IN PATIENTS WITH CONGESTIVE CARDIAC-FAILURE - A PLACEBO-CONTROLLED TRIAL [J].
HAMER, AWF ;
ARKLES, LB ;
JOHNS, JA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (07) :1768-1774
[8]   CLASS-III ANTIARRHYTHMIC AGENTS HAVE A LOT OF POTENTIAL BUT A LONG WAY TO GO - REDUCED EFFECTIVENESS AND DANGERS OF REVERSE USE DEPENDENCE [J].
HONDEGHEM, LM ;
SNYDERS, DJ .
CIRCULATION, 1990, 81 (02) :686-690
[9]  
Josephson M.E., 1993, CLIN CARDIAC ELECTRO, P22
[10]   PROSPECTIVE, RANDOMIZED COMPARISON OF CONVENTIONAL AND HIGH-DOSE LOADING REGIMENS OF AMIODARONE IN THE TREATMENT OF VENTRICULAR-TACHYCARDIA [J].
KALBFLEISCH, SJ ;
WILLIAMSON, B ;
MAN, KC ;
VORPERIAN, V ;
HUMMEL, JD ;
HASSE, C ;
STRICKBERGER, SA ;
CALKINS, H ;
LANGBERG, JJ ;
MORADY, F .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (06) :1723-1729